NasdaqGS - Delayed Quote ? USD Cumberland Pharmaceuticals Inc. (CPIX) Follow Compare 1.2300 +0.0100 (+0.82%) At close: 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cumberland: Q2 Earnings Snapshot CPIX) on Tuesday reported a loss of $1.1 million in its second quarter. On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 8 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 1 cent per share. Associated Press Finance ? 2 months ago CPIX +0.82% Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results and a favorable overall company performance for the second quarter of 2024. PR Newswire ? 2 months ago CPIX +0.82% CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its second quarter 2024 financial results and provide a company update after the market closes on Tuesday, Aug. 6, 2024. PR Newswire ? 2 months ago CPIX +0.82% Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript May 11, 2024 Cumberland Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2024 Financial Report and Company Update. This call […] Insider Monkey ? 5 months ago CPIX +0.82% Cumberland Pharmaceuticals First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.013 profit in 1Q 2023) Cumberland Pharmaceuticals ( NASDAQ:CPIX ) First Quarter 2024 Results Key Financial Results Revenue: US$8.50m (down... Simply Wall St. ? 5 months ago CPIX +0.82% Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call Thomson Reuters StreetEvents ? 5 months ago CPIX +0.82% Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with $82 million in total assets, $54 million in total liabilities and $27 million of shareholders' equity. PR Newswire ? 5 months ago CPIX +0.82% CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024. PR Newswire ? 5 months ago CPIX +0.82% NEW REPORT SUPPORTS USE OF CALDOLOR? AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the release of a Special Report evaluating the growing amount of current data supporting the use of its Caldolor? product (intravenous ibuprofen, or IVIB) as a standard of care for the treatment of pain and fever in adults, children and infants. PR Newswire ? 6 months ago CPIX +0.82% Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript March 5, 2024 Cumberland Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update. This call is being […] Insider Monkey ? 7 months ago CPIX +0.82% Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 loss per share (vs US$0.38 loss in FY 2022) Cumberland Pharmaceuticals ( NASDAQ:CPIX ) Full Year 2023 Results Key Financial Results Revenue: US$39.6m (down 5.9... Simply Wall St. ? 7 months ago CPIX +0.82% Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call Thomson Reuters StreetEvents ? 7 months ago CPIX +0.82% Cumberland Pharmaceuticals Reports Annual 2023 Financial Results Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $40 million in 2023 and provided $6 million in cash generated from operations. PR Newswire ? 7 months ago CPIX +0.82% CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2023 financial results and provide a company update after the market closes on Tuesday, March 5, 2024. PR Newswire ? 7 months ago CPIX +0.82% Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Third Quarter 2023 Company Update and Financial Report. This call is being recorded at Cumberland’s request and will be archived on the company’s website for one year from today’s date. I would now like to […] Insider Monkey ? 11 months ago CPIX +0.82% Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $10.1 million during the third quarter of 2023 and $30.2 million year to date. PR Newswire ? 11 months ago CPIX +0.82% CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the third quarter 2023 financial results and provide a company update after the market closes on Tuesday, Nov. 7, 2023. PR Newswire ? 11 months ago CPIX +0.82% Performance Overview Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return CPIX S&P 500 YTD -31.28% +22.67% 1-Year -42.25% +38.52% 3-Year -53.93% +28.60%
